The authors of this review article describe among other things the results of phase III studies of the tetravalent HPV vaccine gardasil. They conclude: "Overall, these results show that a reduction in anogenital diseases including cervical cancers is already observed in all the vaccinated women in the first three years after the vaccination." Given that no cervical carcinomas were observed neither in the placebo nor the vaccinated group, I would welcome clarification as to the evidence base for the claim for a reduction in cervical cancers.
Footnotes
Conflict of interest statement
The authors declare that no conflict of interest exists according to the guidelines of the International Committee of Medical Journal Editors.